Eli Lilly (LLY) Total Current Liabilities (2009 - 2026)

Eli Lilly (LLY) has reported Total Current Liabilities for 18 consecutive years, with $36.6 billion the latest figure, recorded in Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $36.6 billion, up 21.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $36.6 billion (up 21.84% YoY), and the FY2025 annual result was $35.2 billion, up 24.15% from the prior year.
• Total Current Liabilities was $36.6 billion for Q1 2026 at Eli Lilly, up from $35.2 billion in the prior quarter.
• Over five years, Total Current Liabilities peaked at $40.1 billion in Q3 2025 and troughed at $13.4 billion in Q1 2022.
• Average Total Current Liabilities over 5 years is $25.1 billion, with a median of $24.7 billion recorded in 2024.
• Year-over-year, Total Current Liabilities rose 3.49% in 2022 and soared 62.68% in 2025.
• Over 5 years, Total Current Liabilities stood at $17.1 billion in 2022, then jumped by 59.25% to $27.3 billion in 2023, then rose by 3.97% to $28.4 billion in 2024, then rose by 24.15% to $35.2 billion in 2025, then climbed by 3.99% to $36.6 billion in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $36.6 billion in Q1 2026, $35.2 billion in Q4 2025, and $40.1 billion in Q3 2025.